mapping the effectiveness and risks of glp 1 GLP-1 receptor agonists Mapping the effectiveness and risks
Description
Does Zepbound cause fever
2024;385(6706):258-260
Doug Long, IQVIAs VP of Industry Relations, and Scott Biggs, the companys Director of Supplier Services, teamed in the presentation taking on the landscape of issues shaping the U.S
